PlainRecalls
FDA Drug Moderate Class II Ongoing

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Reported: January 7, 2026 Initiated: December 19, 2025 #D-0245-2026

Product Description

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Reason for Recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Details

Recalling Firm
Novo Nordisk Inc.
Units Affected
N/A
Distribution
Nationwide within the United States.
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14. Recalled by Novo Nordisk Inc.. Units affected: N/A.
Why was this product recalled?
Presence of Particulate Matter: Hair was found in a prefilled syringe
Which agency issued this recall?
This recall was issued by the FDA Drug on January 7, 2026. Severity: Moderate. Recall number: D-0245-2026.